Cargando…

Right ventricule-specific therapies in ARDS: other vasodilating agents to be considered

Detalles Bibliográficos
Autores principales:	Ymeraj, Senada, Attou, Rachid, Redant, Sebastien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071750/ https://www.ncbi.nlm.nih.gov/pubmed/37013621 http://dx.doi.org/10.1186/s13054-023-04419-4

Ejemplares similares

The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
por: Honore, Patrick M., et al.
Publicado: (2020)

PSP is a promising biomarker of sepsis; however, potential elimination by RRT must be considered
por: Honore, Patrick M., et al.
Publicado: (2022)

High doses of ketamine to improve neuronal edema in subarachnoid hemorrhage: we should consider other undesirable organ targets
por: Honore, Patrick M., et al.
Publicado: (2020)

Significance of Hypernatremia Due to SARS-CoV-2 Associated ARDS in Critically Ill Patients
por: Redant, Sébastien, et al.
Publicado: (2020)

Adenosine as pulmonary vasodilator in ARDS
por: Molina, JM, et al.
Publicado: (1998)

A report on pneumonia-induced ventriculitis with intraventricular abscess
por: Gui, Yong-Gang, et al.
Publicado: (2021)

A Study Revealed That a High Percentage of Patients With Severe COVID-19 With Viral RNAaemia Had Significantly Worse Outcomes, and This Is the First Report About the Risk Factors of Viral RNAaemia in Patients With COVID-19: We Are Not Sure!
por: Honore, Patrick M., et al.
Publicado: (2021)

Spontaneous Pneumothorax (SP) in COVID-19 Is Associated With Worse Outcomes Than SP in Non-COVID-19 Patients, Which Suggests That SP in COVID-19 is a Sign of Disease Severity: Is This Finding a Pure Association or Is There Really a Strong Relationship Between the Two?
por: Honore, Patrick M., et al.
Publicado: (2021)

COVID-19 ARDS: getting ventilation right
por: Pérez-Fernández, Xosé L, et al.
Publicado: (2022)

SARS-CoV-2 infection as a risk factor for herpesviridae reactivation: consider the potential influence of corticosteroid therapy
por: Honore, Patrick M., et al.
Publicado: (2020)

Patients with emm1/T1 serotype invasive group A streptococci infections demonstrated more renal failure than patients with other serotypes: perhaps we should consider some confounders
por: Honore, Patrick M., et al.
Publicado: (2020)

Is endocan correlated to ARDS severity or an epiphenomenon of thrombo-embolic disease in COVID
por: Honore, Patrick M., et al.
Publicado: (2021)

Difference of 11 years between two periods of VV-ECMO does not impact mortality in large centres: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2022)

Early latency evoked potentials can no longer be considered an infallible predictor of neurologic outcome
por: Honore, Patrick M., et al.
Publicado: (2020)

Early vs. late coronary angiography in cardiac arrest improves survival and preserves renal function: some confounding factors to consider
por: Redant, Sébastien, et al.
Publicado: (2019)

COVID-19 ARDS: getting ventilation right – Authors' reply
por: Barbaro, Ryan P, et al.
Publicado: (2022)

Endostatin shows a useful value for predicting failure to recover from acute kidney injury: some confounders to consider
por: Honore, Patrick M., et al.
Publicado: (2020)

Membrane adsorption in vancomycin treatment is membrane type dependent in CVVHDF: dose correction is crucial
por: Honore, Patrick M., et al.
Publicado: (2022)

Study find that COVID ARDS was associated with a low risk for possible or proven PCP: still true after dexamethasone use
por: Honore, Patrick M., et al.
Publicado: (2022)

Endarterectomy treatment for patients suffering from a new episode of pulmonary embolism, after screening for chronic thromboembolic pulmonary hypertension
por: Honore, Patrick M., et al.
Publicado: (2022)

Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider
por: Honore, Patrick M., et al.
Publicado: (2020)

Indirect calorimetry is the gold standard to assess REE in ICU patients: some limitations to consider
por: Honore, Patrick M., et al.
Publicado: (2021)

N-terminal pro-brain natriuretic peptide levels during the acute phase of sepsis may be a useful indicator of higher risk of long-term impairments: some confounders to consider
por: Honore, Patrick M., et al.
Publicado: (2020)

Austrian recommendations for best clinical practice in case of haemorrhagic traumatic brain injury under platelet inhibitors or non-vitamin K antagonist oral anticoagulants: an additional therapeutic option to consider
por: Honore, Patrick M., et al.
Publicado: (2020)

Higher incidence of arrhythmia in COVID-19 than in other community-acquired pneumonia: possible role of concurrent therapies
por: Honore, Patrick M., et al.
Publicado: (2021)

Adsorption and caspofungin dosing during continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2019)

Tuberculosis complicated by ARDS
por: Arevalo-Lorido, J. C., et al.
Publicado: (2001)

Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
por: Honore, Patrick M., et al.
Publicado: (2019)

Treatment of influenza virus-related critical illness during continuous renal replacement therapy: take caution with dosing
por: Honore, Patrick M., et al.
Publicado: (2020)

Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose
por: Honore, Patrick M., et al.
Publicado: (2018)

Ventriculitis: Infection or Inflammation
por: Ramanan, Mahesh, et al.
Publicado: (2021)

Clostridioides difficile infection in the critically ill: what kind of therapy for refractory cases
por: Honore, Patrick M., et al.
Publicado: (2020)

No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Ketamine-induced cholangiopathy in ARDS patients
por: de Tymowski, Christian, et al.
Publicado: (2021)

Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure
por: Honore, Patrick M., et al.
Publicado: (2020)

Thrombolytic therapy during resuscitation for pulmonary embolism-related out-of-hospital cardiac arrest: perhaps not the ideal solution for everyone
por: Honore, Patrick M., et al.
Publicado: (2020)

The challenge of removal of sepsis markers by continuous hemofiltration
por: Honore, Patrick M., et al.
Publicado: (2019)

Mechanism of arrhythmias during the infusion of Ringer’s acetate and Ringer’s lactate solutions during cardiac surgery: new insights
por: Redant, Sébastien, et al.
Publicado: (2019)

Who may benefit most from future vitamin D intervention trials: do not forget patients on continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2020)

Vitamin C Dosing During Continuous Renal Replacement Therapy: The Last Word is Not Said!
por: Honore, Patrick M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_avtq2mbsbvdsdtvfoco0tmgpuj